![]() |
市場調査レポート
商品コード
1744441
医療用放射線遮蔽の世界市場:製品・用途・エンドユーザー・地域別の機会および予測 (2018-2032年)Global Medical Radiation Shielding Market Assessment, By Products, By Application, By End-user, By Region, Opportunities and Forecast, 2018-2032F |
||||||
カスタマイズ可能
|
医療用放射線遮蔽の世界市場:製品・用途・エンドユーザー・地域別の機会および予測 (2018-2032年) |
出版日: 2025年06月10日
発行: Market Xcel - Markets and Data
ページ情報: 英文 235 Pages
納期: 3~5営業日
|
世界の医療用放射線遮蔽の市場規模は、2025-2032年の予測期間中にCAGR 6.35%で推移し、2024年の15億1,000万米ドルから、2032年には24億7,000万米ドルに成長すると予測されています。がんや慢性疾患の患者数の増加、技術の進歩、安全意識プロトコル、医療インフラの開発により、急速な成長を遂げています。
世界の医療用放射線遮蔽の市場は、放射線を利用した医療画像診断や治療が増加し、放射線安全の必要性に対する認識が高まっていることから、急速なペースで成長しており、今後も成長が続くと予想されています。医療機関が新たに高度な画像診断装置(CTスキャン、PET-CT、放射線治療システムなど)を導入する中で、有害な放射線から患者を守るための適切な遮蔽方法を確保することが、ますます重要な課題となっています。このような放射線遮蔽システムは、電離放射線から患者および医療従事者の安全を確実に守るものです。また、同市場では、画像診断や検査サービスの提供における医療・職業上のさまざまな安全面の向上や、より複雑化する放射線科の設備、さらには合理的な放射線防護基準の厳守に関する環境規制の影響によっても成長が見られています。医療環境が世界、特に新興国を中心に拡大する中で、鉛やタングステン、新たな鉛フリー素材などの遮蔽材料の入手可能性も高まると見込まれています。また、モバイル画像診断やAIによる線量モニタリングなど、技術革新も新たな遮蔽ソリューションの開発を後押ししています。
当レポートでは、世界の医療用放射線遮蔽の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分別の詳細分析、産業構造、市場成長への影響因子の分析、競合情勢、主要企業のプロファイルなどをまとめています。
Global medical radiation shielding market is projected to witness a CAGR of 6.35% during the forecast period 2025-2032, growing from USD 1.51 billion in 2024 to USD 2.47 billion in 2032. The global medical radiation shielding market is experiencing rapid growth due to the rising cases of cancer and chronic disease, advancements implementation in technology, safety awareness protocols, and the development of healthcare infrastructure.
The global medical radiation shielding market is growing at a rapid pace and will likely continue to grow with the increase in medical imaging and treatment utilizing radiation, along with greater awareness surrounding the necessity of radiation safety. As healthcare providers acquire new and more advanced imaging modalities (CT scans, PET-CT, and radiation therapy systems), ensuring accurate shielding methods for patients from harmful radiation is an ever-increasing concern. This radiation shielding system will dependably guarantee the safety of patients and medical staff from ionizing radiation. The medical radiation shielding market has also seen an increase in various aspects of medical and occupational safety in delivering imaging/examination services and increasingly complex radiology departments, as well as environmental regulations concerning strict adherence to rational protection standards. The availability of shielding materials (lead, tungsten, and new lead-free materials) is expected to increase as medical healthcare environments continue to scale globally (the vast majority in emerging economies). The development of new shielding solutions is also being driven by developments in technology (mobile imaging and AI-enabled dose monitoring).
Furthermore, to ensure patient safety in February 2023, to reduce unnecessary radiation, and to enhance diagnosis, companies are launching new age technologies like mobile X-rays to ensure the lowest amount of radiation. It is also easy to use, lightweight, and good for intensive care unit (ICU) patients.
Increasing Awareness of Chronic Diseases
The increasing cases of chronic diseases such as cancer, cardiovascular diseases, and neurological diseases will enhance the radiation shielding market. Chronic diseases often require repeated diagnostic imaging studies (X-ray, CT scan, PET scan) for early detection, diagnosis, and ongoing observation. Radiation therapy is also a mainstay of treatment for various malignant conditions, which leads to a further increase in demand for effective shielding in cancer treatment centers. Overall, the medical conditions will increase the incidence and subsequently, the management, of their associated procedures, and these procedures frequently utilize ionizing radiation, which will drive the need for good, effective protection for patients and healthcare workers to safeguard against harmful exposure. These points contribute to an excellent opportunity for market growth.
For instance, in January 2025, the American Cancer Society projected that 2,041,910 new cancer cases and 618,120 cancers deaths would occur in the United States in these years, which increased the demand for radiotherapy imaging.
Increasing Awareness of Radiation Safety Protocols
Increasing awareness of radiation safety protocols for healthcare personnel, patients, and regulators is one of the key parameters driving the global medical radiation shielding market. Many are rightly concerned with the long-term effects of exposure to ionizing radiation and potential health effects such as cancer, cataracts, and genetic damage. This is the basis for the ALARA (As Low As Reasonably Achievable) policy and principle in radiation safety. ALARA is about minimizing any possible unnecessary exposure and trying to have clinically effective procedures. Because of this healthcare organizations are establishing effective shielding practices, i.e. room shielding, personal protective equipment like lead aprons and thyroid shields, mobile shielding equipment, etc., the need for radiation safety training is establishing safety culture and trust towards the healthcare system in many of these areas, it increases demand for medical shielding materials to be able to provide timely access safety measures with dependable, high-performance shielding systems, as expected by the medical community when providing a shielding solution.
Additionally, to protect patients and healthcare workers from radiation exposure in February 2023, Specialist Door Solutions (SDS) has proudly launched their Shieldoor lead-lined, x-ray doors for protecting not just from harmful radiation and x-ray exposure but also protecting against the rugged and demanding environments of hospitals and radiology.
Technology Advancement in Imaging and Therapy
Technological advancements in imaging capacity and radiation therapy have markedly improved imaging diagnostic accuracy and therapeutic precision in modern healthcare. Alongside technological innovation, such as photon-counting CT (PCCT), PET-CT, intensity-modulated radiation therapy (IMRT), proton therapy, and adaptive radiotherapy have unquestionably improved patient outcomes while complicating patient and staff risk exposures through increased radiation levels, multi-angle beam delivery of radiation, and longer procedures. It has led to increasing demand for advanced radiation shielding solutions, including shielding via thick concrete walls, neutron-absorbing walls for proton therapy, lightweight composite materials, modular panels, smart shielding systems, and other devices. Further complicating these imaging and technology solutions, healthcare facilities are required to upgrade shielding to not only meet safety but also regulatory needs.
For instance, in May 2024, as part of the Chinese Academy of Sciences, Hefei Institutes of Physical Science created a new type of composite material for shielding degradation due to neutron and gamma radiation. The researchers used micron plate Sm2O3, a rare-earth-based filler, to improve the boron-based polyethylene composite.
Government Initiatives Act as a Catalyst
Government efforts are supporting growth in the field of medical radiation shielding through regulatory authorities such as the US Nuclear Regulatory Commission (NRC), the Food and Drug Administration (FDA), and in India, the Atomic Energy Regulatory Board (AERB), developing strict regulations on radiation safety in health care. Similar to government initiatives promoting business growth, many governments provide funding for projects to improve the healthcare infrastructure, to guarantee that new healthcare facilities invest in medical radiation shielding technology. Government programs enhance knowledge and training regarding radiation safety, foster investment in safer options, and create safety protocols for new medical technologies, which inevitably leads to a demand for advanced radiation shielding. Additionally, the rising shift towards lead-free options is influencing market dynamics and creating opportunities for producers and suppliers to create more sustainable and safer shielding materials.
Additionally, the government is also taking care of healthcare professionals by reducing the burden of workload by launching and updating radiation safety rules. For instance, in January 2023, the FDA announced a final rule that greatly reduces record-keeping requirements for X-ray medical devices, among others. According to the agency, this action will greatly reduce the administrative burdens for it and the medical device industry and will try to reduce unnecessary and duplicative regulatory requirements.
Diagnostic Centers Hold Largest Market Shares
Diagnostic shielding takes the lead in medical radiation shielding due to the massive number of diagnostic imaging that are done all over the world, which is more than radiation therapy. Diagnostic imaging involves millions of different procedures in the world of healthcare, and that encompasses multiple modalities; X-rays, CT scans, mammograms, and fluoroscopy all taking place at different healthcare systems from large hospitals to small clinics. This creates a very large and steady demand for shielding for walls, doors, windows, and personal protective equipment (PPE). With the growing focus on routine screenings and early detection of diseases, this volume is only growing.
Additionally, the Government also supports this market by opening imaging centers. For instance, in October 2023, the Health and Social Care secretary announced that they are targeting to open 160 diagnostic centers from the previous year 2024, but their original target is 2025 to speed up access to potentially lifesaving tests and checks.
North America Dominates the Radiation Shielding Market
North America leads the market for medical radiation shielding because of its modular infrastructure and healthcare resources, as there are large numbers of hospitals and diagnostic facilities available, which encompass many more options for imaging and radiation therapy. Not only does North America have availability in terms of healthcare resources, but it also has structural guidelines regulating radiation safety; this suggests concern for the strength of radiation safety because of high levels of oversight from regulatory entities like the US Nuclear Radiation Commission (NRC) and the Food and Drugs Administration (FDA). There have been significant levels of safety and clinical indications for medical radiation use with chronic diseases and illnesses like cancer that are associated with high numbers of radiation diagnostic and treatment uses. North America is consistently engaged in and applies technological innovations in medical imaging and radiation therapy, enabling healthcare facilities to invest in advanced and tailored solutions for their medical shielding.
To support this region in January 2024, Canada SDI announced that they will collaborate with Artemis Shielding for an alternative solution to lead-based radiation shielding for customers in Canada. This collaboration also helps Artemis to generate revenue and set the stage for innovation because this region is leading to chronic diseases and the opening of diagnostic centers.
Impact of U.S. Tariffs on Global Medical Radiation Shielding Market
The impact of U.S. tariffs on the medical radiation shielding market due to:
Increased Costs: Tariffs raise the price of raw materials and finished goods being imported, creating higher prices for hospitals and patients.
Supply Chain Changes: Manufacturers may change the sources or manufacturing process to avoid tariffs, causing delays or added costs.
Decreased Innovation: Increased costs and uncertainty might reduce incentives for manufacturers to invest in research and inventions into future shielding technologies.
Changes to Competition: Domestic U.S. manufacturers may gain advantages, while U.S. suppliers could face countervailing tariffs.
Concerns about Healthcare Affordability: Increased costs of equipment will add strain on healthcare budgets and may impact access to needed services.
Key Players Landscape and Outlook
Key players are differentiating themselves through ongoing product innovation, utilizing lead-free or less toxic materials, and through mergers and acquisitions that enhance their portfolio and global presence. The primary competitive advantages for these firms lie in their technological expertise, commitment to safety regulations, and extensive distribution networks that cater to hospitals and diagnostic facilities worldwide. Companies are going toward partnerships and collaboration to generate revenue and maintain market trends.
For instance, in February 2025, BIOTRONIK announced it is partnering with radiation protection technology company Egg Medical, Inc., to enhance radiation protection for healthcare professionals as well as their patients. The main reason is to provide excellence in life.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.